Skip to main content

Table 3 Hazard ratios for predicting first cardiovascular disease based on to lipid profile tertiles of participants without prevalent CVD (n = 5054); Tehran Lipid and Glucose Study (TLGS) (2001–2012)

From: Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population

 

Model 1

  

Model 2

   

Tertiles of variables

Tertiles of variables

P for trend*

1

2

3

1

2

3

 

Men

       

 TC, mmol/L

Reference

1.28(1.02-1.6)

1.96(1.56-2.46)

Reference

1.28(1.02-1.61)

1.84(1.46-2.32)

<0.001

 LDL-C, mmol/L

Reference

1.36(1.08-1.71)

1.88(1.49-2.36)

Reference

1.38(1.09-1.74)

1.76(1.39-2.23)

<0.001

 HDL-C, mmol/L

Reference

0.90(0.72-1.12)

0.81(0.64-1.02)

Reference

0.94(0.75-1.17)

0.92(0.72-1.31)

0.44

 Non-HDL-C, mmol/L

Reference

1.35 (1.07-1.7)

1.86 (1.48-2.33)

Reference

1.35 (1.07-1.70)

1.72 (1.36-2.18)

<0.001

 TGs, mmol/L

Reference

1.24(0.98-1.57)

1.55(1.24-1.95)

Reference

1.1(0.87-1.4)

1.25(0.98-1.60)

0.07

 TC/HDL-C

Reference

1.35(1.05-1.73)

1.74(1.37-2.21)

Reference

1.25(0.97-1.61)

1.54(1.2-1.98)

0.001

 TGs/HDL-C

Reference

1.32(1.03-1.68)

1.63(1.29-2.06)

Reference

1.20(0.93-1.54)

1.34(1.04-1.72)

0.02

Women

       

 TC, mmol/L

Reference

1.72(1.18-2.52)

2.23(1.57-3.18)

Reference

1.64(1.20-2.40)

1.98(1.39-2.83)

<0.001

 LDL-C, mmol/L

Reference

1.89(1.32-2.72)

2.36(1.67-3.32)

Reference

1.79(1.25-2.58)

2.09(1.48-2.96)

<0.001

 HDL-C, mmol/L

Reference

1.14(0.84-1.54)

0.87(0.66-1.14)

Reference

1.19(0.88-1.61)

0.95(0.72-1.26)

0.49

 Non-HDL-C, mmol/L

Reference

1.71 (1.19-2.45)

2.39 (1.7-3.36)

Reference

1.57 (1.09-2.27)

2.09 (1.48-2.95)

<0.001

 TGs, mmol/L

Reference

1.39(1.02-1.89)

2.09(1.57-2.79)

Reference

1.17(0.85-1.60)

1.5(1.1-2.03)

0.006

 TC/HDL-C

Reference

1.56(1.17-2.07)

2.08(1.57-2.74)

Reference

1.39(1.04-1.86)

1.78(1.34-2.36)

<0.001

 TGs/HDL-C

Reference

1.45(1.1-1.91)

1.75(1.33-2.31)

Reference

1.23(0.93-1.62)

1.33(1.0-1.77)

0.05

Total

       

 TC, mmol/L

Reference

1.39(1.15-1.68)

2.02(1.68-2.43)

Reference

1.36(1.12-1.66)

1.85(1.53-2.23)

<0.001

 LDL-C, mmol/L

Reference

1.5(1.23-1.81)

2.01(1.67-2.42)

Reference

1.48(1.22-1.79)

1.84(1.52-2.22)

<0.001

 HDL-C, mmol/L

Reference

0.97(0.82-1.16)

0.82(0.69-0.97)

Reference

1.01(0.85-1.21)

0.92(0.77-1.09)

0.34

 Non-HDL-C

Reference

1.44(1.19-1.75)

2.03(1.69-2.44)

Reference

1.39(1.15-1.70)

1.82(1.51-2.20)

<0.001

 TGs, mmol/L

Reference

1.29(1.07-1.55)

1.77(1.48-2.11)

Reference

1.12(0.92-1.35)

1.35(1.12-1.63)

0.001

 TC/HDL-C

Reference

1.44(1.19-1.73)

1.89(1.58-2.26)

Reference

1.31(1.08-1.58)

1.63(1.35-1.96)

<0.001

 TGs/HDL-C

Reference

1.37(1.15-1.65)

1.69(1.42-2.02)

Reference

1.21(1.001-1.45)

1.33(1.11-1.61)

0.003

  1. Model 1: lipid profile tertiles + gender (for total population); model 2 = model 1 + blood pressure status (i.e. normotension, prehypertension and hypertension status), glucose tolerance status (normal glucose tolerance, prediabetes and diabetes), education status, low physical activity, current smoker, lipid lowering drugs and body mass index
  2. CVD cardiovascular disease, TC total cholesterol, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, TGs triglycerides, CI confidence interval. *P-values were calculated using age scale Cox proportional hazards regression models